Annual Income Statements for Lineage
This table shows Lineage's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for Lineage
This table shows Lineage's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
Metric |
|
Q2 2023 |
Q3 2023 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Net Income / (Loss) Attributable to Common Shareholders |
|
-5.00 |
-39 |
-68 |
-485 |
0.00 |
Consolidated Net Income / (Loss) |
|
-8.00 |
-50 |
-80 |
-543 |
0.00 |
Net Income / (Loss) Continuing Operations |
|
-8.00 |
-50 |
-80 |
-543 |
0.00 |
Total Pre-Tax Income |
|
-8.00 |
-55 |
-73 |
-588 |
8.00 |
Total Revenue |
|
-3.00 |
-5.00 |
2.00 |
8.00 |
16 |
Net Interest Income / (Expense) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Interest Income |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Non-Interest Income |
|
-3.00 |
-5.00 |
2.00 |
8.00 |
16 |
Net Realized & Unrealized Capital Gains on Investments |
|
-3.00 |
-5.00 |
2.00 |
8.00 |
16 |
Total Non-Interest Expense |
|
-111 |
-97 |
-74 |
515 |
-56 |
Other Operating Expenses |
|
1,029 |
1,021 |
1,018 |
1,040 |
1,030 |
Depreciation Expense |
|
136 |
137 |
164 |
156 |
158 |
Amortization Expense |
|
52 |
51 |
55 |
54 |
54 |
Impairment Charge |
|
3.00 |
4.00 |
15 |
8.00 |
-21 |
Restructuring Charge |
|
15 |
19 |
12 |
592 |
15 |
Other Special Charges |
|
-1,346 |
-1,329 |
-1,338 |
-1,335 |
-1,292 |
Nonoperating Income / (Expense), net |
|
-116 |
-147 |
-149 |
-81 |
-64 |
Income Tax Expense |
|
0.00 |
-5.00 |
7.00 |
-45 |
8.00 |
Net Income / (Loss) Attributable to Noncontrolling Interest |
|
-3.00 |
-11 |
-12 |
-58 |
0.00 |
Basic Earnings per Share |
|
($0.08) |
($0.26) |
($0.46) |
($2.44) |
$0.01 |
Weighted Average Basic Shares Outstanding |
|
162M |
162M |
162M |
210M |
228M |
Diluted Earnings per Share |
|
($0.08) |
($0.26) |
($0.46) |
($2.44) |
$0.01 |
Weighted Average Diluted Shares Outstanding |
|
162M |
162M |
162M |
210M |
228M |
Weighted Average Basic & Diluted Shares Outstanding |
|
- |
- |
227.69M |
228.41M |
228.59M |
Annual Cash Flow Statements for Lineage
This table details how cash moves in and out of Lineage's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
Metric |
2022 |
2023 |
2024 |
Net Change in Cash & Equivalents |
-38 |
-131 |
104 |
Net Cash From Operating Activities |
501 |
796 |
703 |
Net Cash From Continuing Operating Activities |
501 |
796 |
703 |
Net Income / (Loss) Continuing Operations |
-76 |
-96 |
-751 |
Consolidated Net Income / (Loss) |
-76 |
-96 |
-751 |
Provision For Loan Losses |
5.00 |
6.00 |
5.00 |
Depreciation Expense |
678 |
760 |
876 |
Amortization Expense |
17 |
21 |
19 |
Non-Cash Adjustments to Reconcile Net Income |
2.00 |
3.00 |
609 |
Changes in Operating Assets and Liabilities, net |
-125 |
102 |
-55 |
Net Cash From Investing Activities |
-2,369 |
-1,066 |
-919 |
Net Cash From Continuing Investing Activities |
-2,369 |
-1,066 |
-919 |
Purchase of Property, Leasehold Improvements and Equipment |
-813 |
-766 |
-691 |
Purchase of Investment Securities |
-1,652 |
-319 |
-355 |
Sale and/or Maturity of Investments |
3.00 |
19 |
127 |
Net Cash From Financing Activities |
1,840 |
136 |
320 |
Net Cash From Continuing Financing Activities |
1,829 |
136 |
320 |
Issuance of Debt |
3,411 |
1,431 |
6,593 |
Issuance of Common Equity |
0.00 |
-6.00 |
4,879 |
Repayment of Debt |
-2,255 |
-1,312 |
-10,624 |
Repurchase of Common Equity |
0.00 |
-12 |
-42 |
Payment of Dividends |
-191 |
-46 |
-234 |
Other Financing Activities, Net |
864 |
81 |
-252 |
Effect of Exchange Rate Changes |
-10 |
3.00 |
0.00 |
Cash Interest Paid |
354 |
594 |
523 |
Cash Income Taxes Paid |
74 |
31 |
36 |
Quarterly Cash Flow Statements for Lineage
This table details how cash moves in and out of Lineage's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2023 |
Q4 2023 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Net Change in Cash & Equivalents |
|
-29 |
-41 |
336 |
-237 |
22 |
Net Cash From Operating Activities |
|
229 |
231 |
186 |
257 |
139 |
Net Cash From Continuing Operating Activities |
|
229 |
231 |
186 |
257 |
139 |
Net Income / (Loss) Continuing Operations |
|
-50 |
-57 |
-543 |
-80 |
0.00 |
Consolidated Net Income / (Loss) |
|
-50 |
-57 |
-543 |
-80 |
0.00 |
Provision For Loan Losses |
|
2.00 |
2.00 |
1.00 |
2.00 |
1.00 |
Depreciation Expense |
|
188 |
203 |
210 |
236 |
212 |
Amortization Expense |
|
5.00 |
5.00 |
4.00 |
3.00 |
2.00 |
Non-Cash Adjustments to Reconcile Net Income |
|
21 |
-3.00 |
493 |
97 |
24 |
Changes in Operating Assets and Liabilities, net |
|
63 |
81 |
21 |
-1.00 |
-100 |
Net Cash From Investing Activities |
|
-191 |
-421 |
-138 |
-383 |
-138 |
Net Cash From Continuing Investing Activities |
|
-191 |
-421 |
-138 |
-383 |
-138 |
Purchase of Property, Leasehold Improvements and Equipment |
|
-177 |
-161 |
-153 |
-205 |
-151 |
Acquisitions |
|
- |
-1.00 |
3.00 |
- |
0.00 |
Purchase of Investment Securities |
|
-38 |
-265 |
-39 |
-246 |
-6.00 |
Sale and/or Maturity of Investments |
|
24 |
6.00 |
51 |
71 |
19 |
Net Cash From Financing Activities |
|
-64 |
146 |
284 |
-108 |
21 |
Net Cash From Continuing Financing Activities |
|
-64 |
146 |
284 |
-108 |
21 |
Issuance of Debt |
|
346 |
606 |
1,446 |
308 |
582 |
Repayment of Debt |
|
-395 |
-427 |
-5,883 |
-273 |
-423 |
Repurchase of Common Equity |
|
- |
-9.00 |
- |
-17 |
0.00 |
Payment of Dividends |
|
- |
-46 |
- |
-145 |
-134 |
Other Financing Activities, Net |
|
127 |
28 |
-158 |
19 |
-4.00 |
Effect of Exchange Rate Changes |
|
-3.00 |
3.00 |
4.00 |
-3.00 |
0.00 |
Cash Interest Paid |
|
163 |
148 |
135 |
69 |
86 |
Cash Income Taxes Paid |
|
-10 |
-1.00 |
2.00 |
6.00 |
1.00 |
Annual Balance Sheets for Lineage
This table presents Lineage's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
Metric |
2023 |
2024 |
Total Assets |
18,871 |
18,661 |
Cash and Due from Banks |
68 |
173 |
Restricted Cash |
3.00 |
2.00 |
Trading Account Securities |
113 |
124 |
Loans and Leases, Net of Allowance |
0.00 |
0.00 |
Premises and Equipment, Net |
10,571 |
10,627 |
Goodwill |
3,394 |
3,338 |
Intangible Assets |
1,280 |
1,127 |
Other Assets |
3,442 |
3,270 |
Total Liabilities & Shareholders' Equity |
18,871 |
18,661 |
Total Liabilities |
12,849 |
8,967 |
Short-Term Debt |
134 |
190 |
Other Short-Term Payables |
1,137 |
1,303 |
Long-Term Debt |
10,263 |
6,155 |
Other Long-Term Liabilities |
1,330 |
1,319 |
Commitments & Contingencies |
0.00 |
0.00 |
Redeemable Noncontrolling Interest |
349 |
43 |
Total Equity & Noncontrolling Interests |
5,673 |
9,651 |
Total Preferred & Common Equity |
5,051 |
8,638 |
Preferred Stock |
1.00 |
0.00 |
Total Common Equity |
5,050 |
8,638 |
Common Stock |
5,963 |
10,766 |
Retained Earnings |
-879 |
-1,855 |
Accumulated Other Comprehensive Income / (Loss) |
-34 |
-273 |
Noncontrolling Interest |
622 |
1,013 |
Quarterly Balance Sheets for Lineage
This table presents Lineage's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
Metric |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Total Assets |
18,756 |
19,256 |
18,768 |
Cash and Due from Banks |
73 |
409 |
197 |
Trading Account Securities |
123 |
120 |
128 |
Loans and Leases, Net of Allowance |
0.00 |
0.00 |
0.00 |
Premises and Equipment, Net |
10,491 |
11,324 |
10,644 |
Goodwill |
3,361 |
3,444 |
3,379 |
Intangible Assets |
1,218 |
1,221 |
1,116 |
Other Assets |
3,487 |
2,735 |
3,304 |
Total Liabilities & Shareholders' Equity |
18,756 |
19,256 |
18,768 |
Total Liabilities |
13,002 |
9,134 |
9,122 |
Short-Term Debt |
50 |
136 |
189 |
Other Short-Term Payables |
1,172 |
1,359 |
1,132 |
Long-Term Debt |
10,593 |
4,955 |
5,130 |
Other Long-Term Liabilities |
1,187 |
2,684 |
2,602 |
Commitments & Contingencies |
0.00 |
0.00 |
0.00 |
Redeemable Noncontrolling Interest |
262 |
39 |
41 |
Total Equity & Noncontrolling Interests |
5,492 |
10,083 |
9,605 |
Total Preferred & Common Equity |
4,878 |
9,026 |
8,586 |
Total Common Equity |
4,877 |
9,026 |
8,586 |
Common Stock |
5,983 |
10,746 |
10,793 |
Retained Earnings |
-987 |
-1,662 |
-1,976 |
Accumulated Other Comprehensive Income / (Loss) |
-119 |
-58 |
-231 |
Noncontrolling Interest |
614 |
1,057 |
1,019 |
Annual Metrics And Ratios for Lineage
This table displays calculated financial ratios and metrics derived from Lineage's official financial filings.
Metric |
2022 |
2023 |
2024 |
Growth Metrics |
- |
- |
- |
Revenue Growth |
0.00% |
118.18% |
-1,150.00% |
EBITDA Growth |
0.00% |
21.96% |
-58.41% |
EBIT Growth |
0.00% |
46.18% |
-200.25% |
NOPAT Growth |
0.00% |
46.18% |
-200.25% |
Net Income Growth |
0.00% |
-26.32% |
-682.29% |
EPS Growth |
0.00% |
-43.14% |
-406.85% |
Operating Cash Flow Growth |
0.00% |
58.88% |
-11.68% |
Free Cash Flow Firm Growth |
0.00% |
0.00% |
100.61% |
Invested Capital Growth |
0.00% |
0.00% |
-2.31% |
Revenue Q/Q Growth |
0.00% |
0.00% |
0.00% |
EBITDA Q/Q Growth |
0.00% |
0.00% |
0.00% |
EBIT Q/Q Growth |
0.00% |
0.00% |
0.00% |
NOPAT Q/Q Growth |
0.00% |
0.00% |
0.00% |
Net Income Q/Q Growth |
0.00% |
0.00% |
0.00% |
EPS Q/Q Growth |
0.00% |
0.00% |
0.00% |
Operating Cash Flow Q/Q Growth |
0.00% |
0.00% |
0.00% |
Free Cash Flow Firm Q/Q Growth |
0.00% |
0.00% |
0.00% |
Invested Capital Q/Q Growth |
0.00% |
0.00% |
0.00% |
Profitability Metrics |
- |
- |
- |
EBITDA Margin |
0.00% |
29,575.00% |
0.00% |
EBIT Margin |
0.00% |
10,050.00% |
0.00% |
Profit (Net Income) Margin |
0.00% |
-2,400.00% |
0.00% |
Tax Burden Percent |
108.57% |
87.27% |
89.40% |
Interest Burden Percent |
-25.45% |
-27.36% |
208.44% |
Effective Tax Rate |
0.00% |
0.00% |
0.00% |
Return on Invested Capital (ROIC) |
0.00% |
3.43% |
0.00% |
ROIC Less NNEP Spread (ROIC-NNEP) |
0.00% |
-3.83% |
0.00% |
Return on Net Nonoperating Assets (RNNOA) |
0.00% |
-6.62% |
0.00% |
Return on Equity (ROE) |
0.00% |
-3.19% |
-9.56% |
Cash Return on Invested Capital (CROIC) |
0.00% |
-196.57% |
0.60% |
Operating Return on Assets (OROA) |
0.00% |
2.13% |
0.00% |
Return on Assets (ROA) |
0.00% |
-0.51% |
0.00% |
Return on Common Equity (ROCE) |
0.00% |
-2.67% |
-8.32% |
Return on Equity Simple (ROE_SIMPLE) |
0.00% |
-1.90% |
-8.69% |
Net Operating Profit after Tax (NOPAT) |
193 |
281 |
-282 |
NOPAT Margin |
0.00% |
7,035.00% |
0.00% |
Net Nonoperating Expense Percent (NNEP) |
0.00% |
7.26% |
5.60% |
SG&A Expenses to Revenue |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
0.00% |
-9,950.00% |
0.00% |
Earnings before Interest and Taxes (EBIT) |
275 |
402 |
-403 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
970 |
1,183 |
492 |
Valuation Ratios |
- |
- |
- |
Price to Book Value (P/BV) |
0.00 |
0.88 |
1.55 |
Price to Tangible Book Value (P/TBV) |
0.00 |
11.80 |
3.21 |
Price to Revenue (P/Rev) |
0.00 |
1,109.20 |
0.00 |
Price to Earnings (P/E) |
0.00 |
0.00 |
0.00 |
Dividend Yield |
0.00% |
0.00% |
1.55% |
Earnings Yield |
0.00% |
0.00% |
0.00% |
Enterprise Value to Invested Capital (EV/IC) |
0.00 |
0.96 |
1.28 |
Enterprise Value to Revenue (EV/Rev) |
0.00 |
3,933.70 |
0.00 |
Enterprise Value to EBITDA (EV/EBITDA) |
0.00 |
13.30 |
41.88 |
Enterprise Value to EBIT (EV/EBIT) |
0.00 |
39.14 |
0.00 |
Enterprise Value to NOPAT (EV/NOPAT) |
0.00 |
55.92 |
0.00 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
0.00 |
19.77 |
29.31 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
0.00 |
0.00 |
210.46 |
Leverage & Solvency |
- |
- |
- |
Debt to Equity |
0.00 |
1.73 |
0.65 |
Long-Term Debt to Equity |
0.00 |
1.70 |
0.63 |
Financial Leverage |
0.00 |
1.73 |
1.07 |
Leverage Ratio |
0.00 |
3.13 |
2.39 |
Compound Leverage Factor |
0.00 |
-0.86 |
4.98 |
Debt to Total Capital |
0.00% |
63.32% |
39.56% |
Short-Term Debt to Total Capital |
0.00% |
0.82% |
1.18% |
Long-Term Debt to Total Capital |
0.00% |
62.51% |
38.38% |
Preferred Equity to Total Capital |
0.00% |
0.01% |
0.00% |
Noncontrolling Interests to Total Capital |
0.00% |
5.91% |
6.58% |
Common Equity to Total Capital |
0.00% |
30.76% |
53.86% |
Debt to EBITDA |
0.00 |
8.79 |
12.90 |
Net Debt to EBITDA |
0.00 |
8.73 |
12.54 |
Long-Term Debt to EBITDA |
0.00 |
8.68 |
12.51 |
Debt to NOPAT |
0.00 |
36.95 |
-22.49 |
Net Debt to NOPAT |
0.00 |
36.70 |
-21.87 |
Long-Term Debt to NOPAT |
0.00 |
36.47 |
-21.82 |
Noncontrolling Interest Sharing Ratio |
0.00% |
16.14% |
12.90% |
Liquidity Ratios |
- |
- |
- |
Cash Flow Metrics |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
0.00 |
-16,138 |
98 |
Operating Cash Flow to CapEx |
61.62% |
103.92% |
101.74% |
Free Cash Flow to Firm to Interest Expense |
0.00 |
0.00 |
0.00 |
Operating Cash Flow to Interest Expense |
0.00 |
0.00 |
0.00 |
Operating Cash Flow Less CapEx to Interest Expense |
0.00 |
0.00 |
0.00 |
Efficiency Ratios |
- |
- |
- |
Asset Turnover |
0.00 |
0.00 |
0.00 |
Fixed Asset Turnover |
0.00 |
0.00 |
0.00 |
Capital & Investment Metrics |
- |
- |
- |
Invested Capital |
0.00 |
16,419 |
16,039 |
Invested Capital Turnover |
0.00 |
0.00 |
0.00 |
Increase / (Decrease) in Invested Capital |
0.00 |
16,419 |
-380 |
Enterprise Value (EV) |
0.00 |
15,735 |
20,604 |
Market Capitalization |
4,437 |
4,437 |
13,378 |
Book Value per Share |
$0.00 |
$31.17 |
$37.82 |
Tangible Book Value per Share |
$0.00 |
$2.32 |
$18.27 |
Total Capital |
0.00 |
16,419 |
16,039 |
Total Debt |
0.00 |
10,397 |
6,345 |
Total Long-Term Debt |
0.00 |
10,263 |
6,155 |
Net Debt |
0.00 |
10,326 |
6,170 |
Capital Expenditures (CapEx) |
813 |
766 |
691 |
Net Nonoperating Expense (NNE) |
269 |
377 |
469 |
Net Nonoperating Obligations (NNO) |
0.00 |
10,397 |
6,345 |
Total Depreciation and Amortization (D&A) |
695 |
781 |
895 |
Earnings Adjustments |
- |
- |
- |
Adjusted Basic Earnings per Share |
$0.00 |
$0.00 |
($3.70) |
Adjusted Weighted Average Basic Shares Outstanding |
0.00 |
0.00 |
191M |
Adjusted Diluted Earnings per Share |
$0.00 |
$0.00 |
($3.70) |
Adjusted Weighted Average Diluted Shares Outstanding |
0.00 |
0.00 |
191M |
Adjusted Basic & Diluted Earnings per Share |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
0.00 |
0.00 |
228.20M |
Normalized Net Operating Profit after Tax (NOPAT) |
-3,200 |
-3,394 |
-3,525 |
Normalized NOPAT Margin |
0.00% |
-84,840.00% |
0.00% |
Pre Tax Income Margin |
0.00% |
-2,750.00% |
0.00% |
Debt Service Ratios |
- |
- |
- |
EBIT to Interest Expense |
0.00 |
0.00 |
0.00 |
NOPAT to Interest Expense |
0.00 |
0.00 |
0.00 |
EBIT Less CapEx to Interest Expense |
0.00 |
0.00 |
0.00 |
NOPAT Less CapEx to Interest Expense |
0.00 |
0.00 |
0.00 |
Payout Ratios |
- |
- |
- |
Dividend Payout Ratio |
-251.32% |
-47.92% |
-31.16% |
Augmented Payout Ratio |
-251.32% |
-60.42% |
-36.75% |
Quarterly Metrics And Ratios for Lineage
This table displays calculated financial ratios and metrics derived from Lineage's official financial filings.
Metric |
|
Q2 2023 |
Q3 2023 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Growth Metrics |
|
- |
- |
- |
- |
- |
Revenue Growth |
|
0.00% |
0.00% |
166.67% |
260.00% |
188.89% |
EBITDA Growth |
|
0.00% |
0.00% |
-0.34% |
-202.81% |
-4.67% |
EBIT Growth |
|
0.00% |
0.00% |
-29.63% |
-651.09% |
-13.25% |
NOPAT Growth |
|
0.00% |
0.00% |
-29.63% |
-651.09% |
-100.00% |
Net Income Growth |
|
0.00% |
0.00% |
-900.00% |
-986.00% |
100.00% |
EPS Growth |
|
0.00% |
0.00% |
-475.00% |
-838.46% |
103.57% |
Operating Cash Flow Growth |
|
0.00% |
0.00% |
0.00% |
-18.78% |
32.38% |
Free Cash Flow Firm Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Invested Capital Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Revenue Q/Q Growth |
|
0.00% |
-66.67% |
0.00% |
300.00% |
0.00% |
EBITDA Q/Q Growth |
|
0.00% |
-3.72% |
0.00% |
-199.32% |
0.00% |
EBIT Q/Q Growth |
|
0.00% |
-14.81% |
0.00% |
-767.11% |
0.00% |
NOPAT Q/Q Growth |
|
0.00% |
-14.81% |
0.00% |
-767.11% |
0.00% |
Net Income Q/Q Growth |
|
0.00% |
-525.00% |
0.00% |
-578.75% |
0.00% |
EPS Q/Q Growth |
|
0.00% |
-225.00% |
0.00% |
-430.43% |
0.00% |
Operating Cash Flow Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
-45.91% |
Free Cash Flow Firm Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
4.75% |
0.00% |
Invested Capital Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-7.22% |
0.00% |
Profitability Metrics |
|
- |
- |
- |
- |
- |
EBITDA Margin |
|
0.00% |
0.00% |
14,750.00% |
-3,662.50% |
1,787.50% |
EBIT Margin |
|
0.00% |
0.00% |
3,800.00% |
-6,337.50% |
450.00% |
Profit (Net Income) Margin |
|
0.00% |
0.00% |
-4,000.00% |
-6,787.50% |
0.00% |
Tax Burden Percent |
|
100.00% |
90.91% |
109.59% |
92.35% |
0.00% |
Interest Burden Percent |
|
-7.41% |
-59.78% |
-96.05% |
115.98% |
11.11% |
Effective Tax Rate |
|
0.00% |
0.00% |
0.00% |
0.00% |
100.00% |
Return on Invested Capital (ROIC) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
ROIC Less NNEP Spread (ROIC-NNEP) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Net Nonoperating Assets (RNNOA) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Equity (ROE) |
|
0.00% |
0.00% |
0.00% |
0.00% |
-7.29% |
Cash Return on Invested Capital (CROIC) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Operating Return on Assets (OROA) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Assets (ROA) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Common Equity (ROCE) |
|
0.00% |
0.00% |
0.00% |
0.00% |
-6.49% |
Return on Equity Simple (ROE_SIMPLE) |
|
0.00% |
0.00% |
0.00% |
0.00% |
-8.19% |
Net Operating Profit after Tax (NOPAT) |
|
76 |
64 |
53 |
-355 |
0.00 |
NOPAT Margin |
|
0.00% |
0.00% |
2,660.00% |
-4,436.25% |
0.00% |
Net Nonoperating Expense Percent (NNEP) |
|
0.00% |
0.00% |
2.50% |
7.39% |
0.00% |
SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
|
0.00% |
0.00% |
-3,700.00% |
6,437.50% |
-350.00% |
Earnings before Interest and Taxes (EBIT) |
|
108 |
92 |
76 |
-507 |
72 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
296 |
285 |
295 |
-293 |
286 |
Valuation Ratios |
|
- |
- |
- |
- |
- |
Price to Book Value (P/BV) |
|
0.00 |
0.00 |
0.91 |
1.98 |
1.56 |
Price to Tangible Book Value (P/TBV) |
|
0.00 |
0.00 |
14.89 |
4.09 |
3.27 |
Price to Revenue (P/Rev) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Price to Earnings (P/E) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Dividend Yield |
|
0.00% |
0.00% |
0.00% |
0.48% |
2.45% |
Earnings Yield |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Enterprise Value to Invested Capital (EV/IC) |
|
0.00 |
0.00 |
0.97 |
1.55 |
1.31 |
Enterprise Value to Revenue (EV/Rev) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Enterprise Value to EBITDA (EV/EBITDA) |
|
0.00 |
0.00 |
0.00 |
0.00 |
40.92 |
Enterprise Value to EBIT (EV/EBIT) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Enterprise Value to NOPAT (EV/NOPAT) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
|
0.00 |
0.00 |
0.00 |
0.00 |
26.54 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Leverage & Solvency |
|
- |
- |
- |
- |
- |
Debt to Equity |
|
0.00 |
0.00 |
1.85 |
0.50 |
0.55 |
Long-Term Debt to Equity |
|
0.00 |
0.00 |
1.84 |
0.49 |
0.53 |
Financial Leverage |
|
0.00 |
0.00 |
1.85 |
0.50 |
0.55 |
Leverage Ratio |
|
0.00 |
0.00 |
3.26 |
1.90 |
1.95 |
Compound Leverage Factor |
|
0.00 |
0.00 |
-3.13 |
2.21 |
0.22 |
Debt to Total Capital |
|
0.00% |
0.00% |
64.91% |
33.46% |
35.54% |
Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.30% |
0.89% |
1.26% |
Long-Term Debt to Total Capital |
|
0.00% |
0.00% |
64.60% |
32.57% |
34.28% |
Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.01% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
|
0.00% |
0.00% |
5.34% |
7.20% |
7.08% |
Common Equity to Total Capital |
|
0.00% |
0.00% |
29.74% |
59.33% |
57.37% |
Debt to EBITDA |
|
0.00 |
0.00 |
0.00 |
0.00 |
11.13 |
Net Debt to EBITDA |
|
0.00 |
0.00 |
0.00 |
0.00 |
10.72 |
Long-Term Debt to EBITDA |
|
0.00 |
0.00 |
0.00 |
0.00 |
10.73 |
Debt to NOPAT |
|
0.00 |
0.00 |
0.00 |
0.00 |
-18.35 |
Net Debt to NOPAT |
|
0.00 |
0.00 |
0.00 |
0.00 |
-17.67 |
Long-Term Debt to NOPAT |
|
0.00 |
0.00 |
0.00 |
0.00 |
-17.70 |
Noncontrolling Interest Sharing Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
10.99% |
Liquidity Ratios |
|
- |
- |
- |
- |
- |
Cash Flow Metrics |
|
- |
- |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
|
0.00 |
0.00 |
-16,344 |
-15,568 |
-14,965 |
Operating Cash Flow to CapEx |
|
0.00% |
129.38% |
0.00% |
121.57% |
92.05% |
Free Cash Flow to Firm to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Operating Cash Flow to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Operating Cash Flow Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Efficiency Ratios |
|
- |
- |
- |
- |
- |
Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
Invested Capital |
|
0.00 |
0.00 |
16,397 |
15,213 |
14,965 |
Invested Capital Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Increase / (Decrease) in Invested Capital |
|
0.00 |
0.00 |
16,397 |
15,213 |
14,965 |
Enterprise Value (EV) |
|
0.00 |
0.00 |
15,881 |
23,621 |
19,561 |
Market Capitalization |
|
4,437 |
4,437 |
4,437 |
17,846 |
13,379 |
Book Value per Share |
|
$0.00 |
$0.00 |
$30.10 |
$39.64 |
$37.63 |
Tangible Book Value per Share |
|
$0.00 |
$0.00 |
$1.84 |
$19.15 |
$17.93 |
Total Capital |
|
0.00 |
0.00 |
16,397 |
15,213 |
14,965 |
Total Debt |
|
0.00 |
0.00 |
10,643 |
5,091 |
5,319 |
Total Long-Term Debt |
|
0.00 |
0.00 |
10,593 |
4,955 |
5,130 |
Net Debt |
|
0.00 |
0.00 |
10,567 |
4,679 |
5,122 |
Capital Expenditures (CapEx) |
|
0.00 |
177 |
0.00 |
153 |
151 |
Net Nonoperating Expense (NNE) |
|
84 |
114 |
133 |
188 |
0.00 |
Net Nonoperating Obligations (NNO) |
|
0.00 |
0.00 |
10,643 |
5,091 |
5,319 |
Total Depreciation and Amortization (D&A) |
|
188 |
193 |
219 |
214 |
214 |
Earnings Adjustments |
|
- |
- |
- |
- |
- |
Adjusted Basic Earnings per Share |
|
$0.00 |
$0.00 |
($0.46) |
($2.44) |
$0.01 |
Adjusted Weighted Average Basic Shares Outstanding |
|
0.00 |
0.00 |
162M |
210M |
228M |
Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
($0.46) |
($2.44) |
$0.01 |
Adjusted Weighted Average Diluted Shares Outstanding |
|
0.00 |
0.00 |
162M |
210M |
228M |
Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
0.00 |
0.00 |
227.69M |
228.41M |
228.59M |
Normalized Net Operating Profit after Tax (NOPAT) |
|
-854 |
-850 |
-865 |
-869 |
-858 |
Normalized NOPAT Margin |
|
0.00% |
0.00% |
-43,225.00% |
-10,867.50% |
-5,363.75% |
Pre Tax Income Margin |
|
0.00% |
0.00% |
-3,650.00% |
-7,350.00% |
50.00% |
Debt Service Ratios |
|
- |
- |
- |
- |
- |
EBIT to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
NOPAT to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
EBIT Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
NOPAT Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Payout Ratios |
|
- |
- |
- |
- |
- |
Dividend Payout Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
-36.42% |
Augmented Payout Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
-38.83% |
Key Financial Trends
Lineage, Inc. (NASDAQ: LINE) Financial Summary and Analysis:
Lineage's recent financial statements for Q1 2025 and prior quarters over the last two years show mixed operational results and cash flow dynamics, with significant expenses impacting profitability along with recent positive developments in capital gains.
- Q1 2025 reported a significant net realized & unrealized capital gain on investments totaling $16 million, doubling from $8 million in Q3 2024, indicating improved investment performance.
- Net cash provided by continuing operating activities was $139 million in Q1 2025, demonstrating strong cash flow generation from operations despite a net income of zero.
- Issuance of debt increased to $582 million in Q1 2025, compared to $308 million in Q4 2024 and $1446 million in Q3 2024, reflecting active financing efforts to support growth or operations.
- Repayment of debt decreased in Q1 2025 to $423 million, from $423 million in Q4 2024 and $588 million in Q3 2024, signaling balance sheet management.
- Cash and due from banks remained solid at $197 million at the end of Q1 2025, a more modest decrease from $409 million in Q3 2024, indicating liquidity maintenance.
- Total assets remained relatively stable around $18.7 billion at Q1 2025 compared to prior periods, with large holdings in premises and equipment ($10.6 billion) and goodwill (~$3.4 billion).
- Depreciation expense remains high around $158 million in Q1 2025, consistent with prior quarters, reflecting ongoing capital asset wear.
- Outstanding shares for basic and diluted EPS were around 228 million shares in Q1 2025, stable over recent periods.
- Despite positive cash flow and capital gains, Net Income remains at zero in Q1 2025, following significant net losses in prior quarters, e.g., -$543 million in Q3 2024 and losses in preceding periods.
- Lineage faces heavy other operating expenses around $1.03 billion and significant special charges (negative $1.29 billion) in Q1 2025 impacting profitability and overall expenses.
- The company recorded a restructuring charge of $15 million in Q1 2025 and had some impairment charges, although one impairment expense was negative (-$21 million indicating a potential reversal), signaling ongoing asset and structural adjustments.
- Cash interest paid in Q1 2025 is substantial at $86 million, reflecting ongoing financing costs.
- Total liabilities were around $9.12 billion at Q1 2025 with long-term debt of about $5.13 billion, indicating significant leverage.
- Retained earnings remain negative at approximately -$1.98 billion as of Q1 2025, reflecting accumulated losses over time.
Key Takeaways for Investors:
- Lineage shows operational cash flow strength with positive cash flow from operations in the latest quarter despite accounting losses.
- Strong capital assets and investments underpin the asset base, but high depreciation and amortization costs depress net income.
- Consistent high operating expenses and large special charges contribute to lack of profitability and negative retained earnings, raising concerns about sustainable earnings.
- High debt levels and interest expense increase financial risk, with leverage remaining a key factor to monitor.
- The recent improvement in investment gains might provide a path to better earnings if operating expenses can be controlled.
Overall, investors should watch Lineage's efforts in managing expenses and restructuring charges while leveraging their asset base and improving capital gains to return to profitability. The company’s strong operating cash flow is a positive, but high leverage and ongoing losses pose risks.
09/13/25 04:36 PM ETAI Generated. May Contain Errors.